Symbol:
Vwa8
Name:
von Willebrand factor A domain containing 8
RGD ID:
1308772
Description:
Predicted to enable ATP hydrolysis activity. Predicted to be located in mitochondrion and peroxisome. Predicted to be active in cytoplasm. Orthologous to human VWA8 (von Willebrand factor A domain containing 8); INTERACTS WITH (+)-schisandrin B; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC290381; RGD1308772; similar to KIAA0564 protein; von Willebrand factor A domain-containing protein 8
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 15 60,661,764 - 60,985,971 (+) NCBI GRCr8 mRatBN7.2 15 54,252,703 - 54,576,871 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 15 54,252,584 - 54,576,870 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 15 61,158,510 - 61,467,462 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 15 61,069,439 - 61,153,292 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 15 61,069,581 - 61,152,506 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 15 64,733,018 - 64,817,848 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 15 65,106,678 - 65,131,504 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 15 59,993,882 - 60,364,838 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 15 59,950,242 - 60,379,537 (+) NCBI Celera 15 53,842,678 - 54,161,011 (+) NCBI Celera Cytogenetic Map 15 q11-q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Vwa8 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VWA8 mRNA] CTD PMID:31150632 Vwa8 Rat 1,2-dimethylhydrazine multiple interactions ISO Vwa8 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VWA8 mRNA CTD PMID:22206623 Vwa8 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of VWA8 mRNA CTD PMID:32145629 Vwa8 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO VWA8 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Vwa8 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of VWA8 mRNA CTD PMID:21215274 Vwa8 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Vwa8 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of VWA8 mRNA CTD PMID:31961203 Vwa8 Rat 2,4,6-tribromophenol increases expression ISO VWA8 (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Vwa8 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO VWA8 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of VWA8 protein CTD PMID:31675489 Vwa8 Rat 4,4'-sulfonyldiphenol increases methylation ISO VWA8 (Homo sapiens) 6480464 bisphenol S results in increased methylation of VWA8 gene CTD PMID:31601247 Vwa8 Rat 4,4'-sulfonyldiphenol affects expression ISO VWA8 (Homo sapiens) 6480464 bisphenol S affects the expression of VWA8 protein CTD PMID:31945527 Vwa8 Rat aristolochic acid A decreases expression ISO VWA8 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of VWA8 mRNA CTD PMID:33212167 Vwa8 Rat arsane affects methylation ISO VWA8 (Homo sapiens) 6480464 Arsenic affects the methylation of VWA8 gene CTD PMID:25304211 Vwa8 Rat arsenic atom affects methylation ISO VWA8 (Homo sapiens) 6480464 Arsenic affects the methylation of VWA8 gene CTD PMID:25304211 Vwa8 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of VWA8 gene CTD PMID:35440735 Vwa8 Rat benzo[a]pyrene decreases expression ISO Vwa8 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of VWA8 mRNA CTD PMID:23735875 Vwa8 Rat benzo[a]pyrene decreases methylation ISO Vwa8 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of VWA8 exon and Benzo(a)pyrene results in decreased methylation of VWA8 intron CTD PMID:27901495 Vwa8 Rat benzo[a]pyrene decreases expression ISO VWA8 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of VWA8 mRNA CTD PMID:21632981 and PMID:26238291 Vwa8 Rat benzo[b]fluoranthene increases expression ISO Vwa8 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of VWA8 mRNA CTD PMID:26377693 Vwa8 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of VWA8 mRNA CTD PMID:25181051 Vwa8 Rat bisphenol A decreases methylation ISO VWA8 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of VWA8 gene CTD PMID:31601247 Vwa8 Rat bisphenol A decreases expression ISO VWA8 (Homo sapiens) 6480464 bisphenol A results in decreased expression of VWA8 protein CTD PMID:31675489 Vwa8 Rat bisphenol A multiple interactions ISO VWA8 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of VWA8 gene CTD PMID:31601247 Vwa8 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of VWA8 mRNA CTD PMID:32145629 Vwa8 Rat bisphenol AF increases expression ISO VWA8 (Homo sapiens) 6480464 bisphenol AF results in increased expression of VWA8 protein CTD PMID:34186270 Vwa8 Rat buspirone increases expression EXP 6480464 Buspirone results in increased expression of VWA8 mRNA CTD PMID:24136188 Vwa8 Rat cadmium atom multiple interactions ISO VWA8 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VWA8 mRNA CTD PMID:35301059 Vwa8 Rat cadmium dichloride decreases expression ISO VWA8 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of VWA8 mRNA CTD PMID:38382870 Vwa8 Rat cadmium dichloride multiple interactions ISO VWA8 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VWA8 mRNA CTD PMID:35301059 Vwa8 Rat carbon nanotube increases expression ISO Vwa8 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 Vwa8 Rat carbon nanotube decreases expression ISO Vwa8 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of VWA8 mRNA CTD PMID:25554681 Vwa8 Rat chlorpyrifos increases expression ISO Vwa8 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of VWA8 mRNA CTD PMID:32715474 Vwa8 Rat chromium(6+) affects expression ISO Vwa8 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of VWA8 mRNA CTD PMID:28472532 Vwa8 Rat clofibrate increases expression ISO Vwa8 (Mus musculus) 6480464 Clofibrate results in increased expression of VWA8 mRNA CTD PMID:23811191 and PMID:25270620 Vwa8 Rat clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of VWA8 mRNA CTD PMID:32741897 Vwa8 Rat crocidolite asbestos decreases methylation ISO VWA8 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased methylation of VWA8 gene CTD PMID:29523930 Vwa8 Rat decabromodiphenyl ether decreases expression ISO VWA8 (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of VWA8 protein CTD PMID:31675489 Vwa8 Rat dorsomorphin multiple interactions ISO VWA8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VWA8 mRNA CTD PMID:27188386 Vwa8 Rat doxorubicin decreases expression ISO VWA8 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of VWA8 mRNA CTD PMID:29803840 Vwa8 Rat entinostat increases expression ISO VWA8 (Homo sapiens) 6480464 entinostat results in increased expression of VWA8 mRNA CTD PMID:26272509 Vwa8 Rat entinostat multiple interactions ISO VWA8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VWA8 mRNA CTD PMID:27188386 Vwa8 Rat ethanol increases expression ISO Vwa8 (Mus musculus) 6480464 Ethanol results in increased expression of VWA8 mRNA CTD PMID:30319688 Vwa8 Rat fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of VWA8 mRNA CTD PMID:32741897 Vwa8 Rat finasteride increases expression EXP 6480464 Finasteride results in increased expression of VWA8 mRNA CTD PMID:24136188 Vwa8 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of VWA8 mRNA CTD PMID:24793618 Vwa8 Rat folic acid multiple interactions ISO Vwa8 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VWA8 mRNA CTD PMID:22206623 Vwa8 Rat FR900359 increases phosphorylation ISO VWA8 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of VWA8 protein CTD PMID:37730182 Vwa8 Rat fulvestrant decreases methylation ISO VWA8 (Homo sapiens) 6480464 Fulvestrant results in decreased methylation of VWA8 gene CTD PMID:31601247 Vwa8 Rat fulvestrant multiple interactions ISO VWA8 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of VWA8 gene CTD PMID:31601247 Vwa8 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of VWA8 mRNA CTD PMID:24136188 Vwa8 Rat ivermectin decreases expression ISO VWA8 (Homo sapiens) 6480464 Ivermectin results in decreased expression of VWA8 protein CTD PMID:32959892 Vwa8 Rat leflunomide increases expression EXP 6480464 leflunomide results in increased expression of VWA8 mRNA CTD PMID:24136188 Vwa8 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of VWA8 gene CTD PMID:35440735 Vwa8 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of VWA8 mRNA CTD PMID:24136188 Vwa8 Rat nimesulide increases expression EXP 6480464 nimesulide results in increased expression of VWA8 mRNA CTD PMID:24136188 Vwa8 Rat paracetamol decreases expression ISO VWA8 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of VWA8 mRNA CTD PMID:21420995 Vwa8 Rat perfluorohexanesulfonic acid increases expression ISO Vwa8 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of VWA8 mRNA CTD PMID:28558994 Vwa8 Rat perfluorononanoic acid increases expression ISO Vwa8 (Mus musculus) 6480464 perfluoro-n-nonanoic acid results in increased expression of VWA8 mRNA CTD PMID:28558994 Vwa8 Rat perfluorooctane-1-sulfonic acid increases expression ISO Vwa8 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of VWA8 mRNA CTD PMID:28558994 Vwa8 Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of VWA8 mRNA CTD PMID:28511854 Vwa8 Rat perfluorooctanoic acid increases expression ISO Vwa8 (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of VWA8 mRNA CTD PMID:28558994 and PMID:30711707 Vwa8 Rat pirinixic acid increases expression ISO Vwa8 (Mus musculus) 6480464 pirinixic acid results in increased expression of VWA8 mRNA CTD PMID:23811191 and PMID:25270620 Vwa8 Rat pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of VWA8 mRNA CTD PMID:32741897 Vwa8 Rat potassium chromate decreases expression ISO VWA8 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of VWA8 mRNA CTD PMID:22714537 Vwa8 Rat quercitrin decreases expression ISO VWA8 (Homo sapiens) 6480464 quercitrin results in decreased expression of VWA8 mRNA CTD PMID:25193878 Vwa8 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of VWA8 mRNA CTD PMID:28374803 Vwa8 Rat SB 431542 multiple interactions ISO VWA8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VWA8 mRNA CTD PMID:27188386 Vwa8 Rat serpentine asbestos increases methylation ISO VWA8 (Homo sapiens) 6480464 Asbestos and Serpentine results in increased methylation of VWA8 gene CTD PMID:29523930 Vwa8 Rat sodium arsenate increases expression ISO Vwa8 (Mus musculus) 6480464 sodium arsenate results in increased expression of VWA8 mRNA CTD PMID:30953684 Vwa8 Rat sodium arsenite increases expression ISO Vwa8 (Mus musculus) 6480464 sodium arsenite results in increased expression of VWA8 mRNA CTD PMID:36209798 Vwa8 Rat sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of VWA8 mRNA CTD PMID:22110744 Vwa8 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VWA8 mRNA] CTD PMID:31150632 Vwa8 Rat tetrachloromethane decreases expression ISO Vwa8 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of VWA8 mRNA CTD PMID:31919559 Vwa8 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of VWA8 mRNA CTD PMID:31150632 Vwa8 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of VWA8 mRNA CTD PMID:30589522 Vwa8 Rat triphenyl phosphate affects expression ISO VWA8 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of VWA8 mRNA CTD PMID:37042841 Vwa8 Rat troglitazone decreases expression ISO Vwa8 (Mus musculus) 6480464 troglitazone results in decreased expression of VWA8 mRNA CTD PMID:28973697 Vwa8 Rat trovafloxacin decreases expression ISO Vwa8 (Mus musculus) 6480464 trovafloxacin results in decreased expression of VWA8 mRNA CTD PMID:35537566 Vwa8 Rat valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of VWA8 mRNA CTD PMID:24136188 Vwa8 Rat valproic acid increases expression ISO VWA8 (Homo sapiens) 6480464 Valproic Acid results in increased expression of VWA8 mRNA CTD PMID:23179753 and PMID:28001369 Vwa8 Rat valproic acid affects expression ISO VWA8 (Homo sapiens) 6480464 Valproic Acid affects the expression of VWA8 mRNA CTD PMID:25979313 Vwa8 Rat valproic acid increases methylation ISO VWA8 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of VWA8 gene CTD PMID:28853863 and PMID:29201983
(+)-schisandrin B (EXP) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (EXP) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-tribromophenol (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 4,4'-sulfonyldiphenol (ISO) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) atrazine (EXP) benzo[a]pyrene (ISO) benzo[b]fluoranthene (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) buspirone (EXP) cadmium atom (ISO) cadmium dichloride (ISO) carbon nanotube (ISO) chlorpyrifos (ISO) chromium(6+) (ISO) clofibrate (EXP,ISO) crocidolite asbestos (ISO) decabromodiphenyl ether (ISO) dorsomorphin (ISO) doxorubicin (ISO) entinostat (ISO) ethanol (ISO) fenofibrate (EXP) finasteride (EXP) flutamide (EXP) folic acid (ISO) FR900359 (ISO) fulvestrant (ISO) glafenine (EXP) ivermectin (ISO) leflunomide (EXP) methoxychlor (EXP) nefazodone (EXP) nimesulide (EXP) paracetamol (ISO) perfluorohexanesulfonic acid (ISO) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP,ISO) pirinixic acid (EXP,ISO) potassium chromate (ISO) quercitrin (ISO) rotenone (EXP) SB 431542 (ISO) serpentine asbestos (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sodium dichromate (EXP) tetrachloromethane (EXP,ISO) triphenyl phosphate (EXP,ISO) troglitazone (ISO) trovafloxacin (ISO) valdecoxib (EXP) valproic acid (ISO)
Vwa8 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 15 60,661,764 - 60,985,971 (+) NCBI GRCr8 mRatBN7.2 15 54,252,703 - 54,576,871 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 15 54,252,584 - 54,576,870 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 15 61,158,510 - 61,467,462 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 15 61,069,439 - 61,153,292 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 15 61,069,581 - 61,152,506 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 15 64,733,018 - 64,817,848 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 15 65,106,678 - 65,131,504 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 15 59,993,882 - 60,364,838 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 15 59,950,242 - 60,379,537 (+) NCBI Celera 15 53,842,678 - 54,161,011 (+) NCBI Celera Cytogenetic Map 15 q11-q12 NCBI
VWA8 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 13 41,566,835 - 41,961,109 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 13 41,566,835 - 41,961,120 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 13 42,140,971 - 42,535,245 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 13 41,038,961 - 41,433,221 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 13 23,199,011 - 23,592,898 (-) NCBI Celera Cytogenetic Map 13 q14.11 NCBI HuRef 13 22,941,888 - 23,338,138 (-) NCBI HuRef CHM1_1 13 42,108,485 - 42,502,867 (-) NCBI CHM1_1 T2T-CHM13v2.0 13 40,785,956 - 41,180,365 (-) NCBI T2T-CHM13v2.0
Vwa8 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 14 79,086,489 - 79,439,750 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 14 79,086,492 - 79,439,750 (+) Ensembl GRCm39 Ensembl GRCm38 14 78,849,058 - 79,202,310 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 14 78,849,052 - 79,202,310 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 14 79,248,985 - 79,602,117 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 14 77,503,772 - 77,936,465 (+) NCBI MGSCv36 mm8 Celera 14 76,362,512 - 76,701,437 (+) NCBI Celera Cytogenetic Map 14 D3 NCBI cM Map 14 41.9 NCBI
Vwa8 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955518 4,351,781 - 4,723,479 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955518 4,351,781 - 4,723,479 (+) NCBI ChiLan1.0 ChiLan1.0
VWA8 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 14 41,065,135 - 41,458,200 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 13 32,168,718 - 32,561,732 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 13 22,750,083 - 23,142,860 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 13 41,339,379 - 41,729,689 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 13 41,339,379 - 41,729,661 (-) Ensembl panpan1.1 panPan2
VWA8 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 22 8,799,044 - 9,153,627 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 22 8,798,090 - 9,149,296 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 22 8,793,300 - 9,146,711 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 22 9,025,235 - 9,379,824 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 22 9,039,291 - 9,376,614 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 22 8,717,913 - 9,072,245 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 22 8,768,009 - 9,122,199 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 22 8,780,057 - 9,133,927 (+) NCBI UU_Cfam_GSD_1.0
LOC101965792 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404945 151,964,945 - 152,276,047 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936747 1,797,136 - 2,064,072 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936747 1,798,200 - 2,018,722 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
VWA8 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 11 25,064,771 - 25,457,134 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 11 25,064,780 - 25,455,287 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 11 25,821,408 - 26,011,445 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
VWA8 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 3 19,767,190 - 20,148,027 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 3 19,866,921 - 20,147,976 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666057 24,064,072 - 24,448,338 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Vwa8
.
Predicted Target Of
Count of predictions: 152 Count of miRNA genes: 117 Interacting mature miRNAs: 133 Transcripts: ENSRNOT00000013780, ENSRNOT00000070840, ENSRNOT00000074956 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1331729 Rf42 Renal function QTL 42 3.071 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 15 17362897 73690657 Rat 724545 Niddm54 Non-insulin dependent diabetes mellitus QTL 54 0.02 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 15 50794494 73699215 Rat 1582227 Gluco30 Glucose level QTL 30 3.6 0.0003 blood glucose amount (VT:0000188) absolute change in blood glucose level area under curve (CMO:0002034) 15 28030665 82262678 Rat 1582228 Epfw3 Epididymal fat weight QTL 3 4.1 0.0002 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 15 28030665 82262678 Rat 1578646 Bmd18 Bone mineral density QTL 18 5.2 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 15 22806240 98288169 Rat 1578647 Bmd17 Bone mineral density QTL 17 4 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 15 22806240 98288169 Rat 2293686 Bmd36 Bone mineral density QTL 36 7.4 0.0001 femur strength trait (VT:0010010) femoral neck ultimate force (CMO:0001703) 15 33611058 71477291 Rat 2317750 Glom26 Glomerulus QTL 26 4.3 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 15 12496141 65205939 Rat 2298549 Neuinf12 Neuroinflammation QTL 12 3.5 nervous system integrity trait (VT:0010566) spinal cord beta-2 microglobulin mRNA level (CMO:0002125) 15 1 55302115 Rat 2293691 Bmd37 Bone mineral density QTL 37 6.6 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 15 33611058 71477291 Rat 2317050 Aia24 Adjuvant induced arthritis QTL 24 2.06 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 15 52847908 73690657 Rat 2293688 Bss29 Bone structure and strength QTL 29 5.31 0.0001 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 15 11111142 56111142 Rat 1582214 Stl21 Serum triglyceride level QTL 21 3.1 0.022 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 15 28030665 82262678 Rat 631273 Lecl2 Lens clarity QTL 2 0.001 lens clarity trait (VT:0001304) age of onset/diagnosis of cataract (CMO:0001584) 15 10596089 55596089 Rat 1300144 Rf23 Renal function QTL 23 3.61 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 15 40631268 98288169 Rat 1576315 Schws6 Schwannoma susceptibility QTL 6 0.0069 nervous system integrity trait (VT:0010566) post-insult time of death (CMO:0002005) 15 53806152 98806152 Rat 2300167 Bmd63 Bone mineral density QTL 63 5.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 15 11111142 56111142 Rat 152025253 Hrtrt24 Heart rate QTL 24 3.82 heart pumping trait (VT:2000009) 15 27885774 86257085 Rat 10054130 Srcrt8 Stress Responsive Cort QTL 8 2.18 0.0085 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 15 22117933 67117933 Rat 2300173 Bmd62 Bone mineral density QTL 62 12.8 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 15 11111142 56111142 Rat 61424 Scl1 Serum cholesterol level QTL 1 7.7 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 15 16725528 80672115 Rat 1598828 Glom14 Glomerulus QTL 14 2.5 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 15 34054139 79054139 Rat 1582242 Gluco28 Glucose level QTL 28 3.3 0.0008 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 15 28030665 82262678 Rat 1578660 Bss19 Bone structure and strength QTL 19 4.3 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 15 22806240 98288169 Rat 1582244 Bw79 Body weight QTL 79 4 0.0002 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 15 28030665 82262678 Rat
D15Got65
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 54,422,038 - 54,422,145 (+) MAPPER mRatBN7.2 Rnor_6.0 15 61,307,664 - 61,307,770 NCBI Rnor6.0 Rnor_5.0 15 64,972,305 - 64,972,411 UniSTS Rnor5.0 RGSC_v3.4 15 60,163,434 - 60,163,540 RGD RGSC3.4 RGSC_v3.4 15 60,163,435 - 60,163,541 UniSTS RGSC3.4 RGSC_v3.1 15 60,179,214 - 60,179,320 RGD Celera 15 54,011,730 - 54,011,836 UniSTS RH 3.4 Map 15 452.3 RGD RH 3.4 Map 15 452.3 UniSTS Cytogenetic Map 15 q11-q12 UniSTS
RH129773
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 54,453,388 - 54,453,540 (+) MAPPER mRatBN7.2 Rnor_6.0 15 61,344,209 - 61,344,360 NCBI Rnor6.0 Rnor_5.0 15 65,009,677 - 65,009,828 UniSTS Rnor5.0 RGSC_v3.4 15 60,201,235 - 60,201,386 UniSTS RGSC3.4 Celera 15 54,038,235 - 54,038,386 UniSTS RH 3.4 Map 15 458.0 UniSTS Cytogenetic Map 15 q11-q12 UniSTS
RH143518
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 54,414,064 - 54,414,339 (+) MAPPER mRatBN7.2 Rnor_6.0 15 61,299,691 - 61,299,965 NCBI Rnor6.0 Rnor_5.0 15 64,964,332 - 64,964,606 UniSTS Rnor5.0 RGSC_v3.4 15 60,155,584 - 60,155,858 UniSTS RGSC3.4 Celera 15 54,003,757 - 54,004,031 UniSTS RH 3.4 Map 15 458.3 UniSTS Cytogenetic Map 18 p11 UniSTS Cytogenetic Map 15 q11-q12 UniSTS Cytogenetic Map 15 q11 UniSTS
RH134704
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 15 60,985,648 - 60,985,920 (+) Marker Load Pipeline mRatBN7.2 15 54,576,552 - 54,576,824 (+) MAPPER mRatBN7.2 Rnor_6.0 15 61,467,144 - 61,467,415 NCBI Rnor6.0 Rnor_5.0 15 65,131,186 - 65,131,457 UniSTS Rnor5.0 RGSC_v3.4 15 60,364,520 - 60,364,791 UniSTS RGSC3.4 Celera 15 54,160,702 - 54,160,964 UniSTS RH 3.4 Map 4 685.32 UniSTS Cytogenetic Map 15 q11-q12 UniSTS
Hars
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 54,415,320 - 54,415,449 (+) MAPPER mRatBN7.2 mRatBN7.2 18 28,382,080 - 28,382,413 (+) MAPPER mRatBN7.2 Rnor_6.0 18 29,611,977 - 29,612,309 NCBI Rnor6.0 Rnor_6.0 15 61,300,947 - 61,301,075 NCBI Rnor6.0 Rnor_5.0 18 29,315,784 - 29,316,116 UniSTS Rnor5.0 Rnor_5.0 15 64,965,588 - 64,965,716 UniSTS Rnor5.0 RGSC_v3.4 18 29,468,080 - 29,468,412 UniSTS RGSC3.4 RGSC_v3.4 15 60,156,840 - 60,156,968 UniSTS RGSC3.4 Celera 15 54,005,013 - 54,005,141 UniSTS Celera 18 28,102,633 - 28,102,965 UniSTS Cytogenetic Map 18 p11 UniSTS Cytogenetic Map 15 q11 UniSTS Cytogenetic Map 15 q11-q12 UniSTS
RH130568
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 18 28,381,729 - 28,381,937 (+) MAPPER mRatBN7.2 mRatBN7.2 15 54,415,592 - 54,415,947 (+) MAPPER mRatBN7.2 Rnor_6.0 15 61,301,219 - 61,301,573 NCBI Rnor6.0 Rnor_6.0 18 29,611,626 - 29,611,833 NCBI Rnor6.0 Rnor_5.0 18 29,315,433 - 29,315,640 UniSTS Rnor5.0 Rnor_5.0 15 64,965,860 - 64,966,214 UniSTS Rnor5.0 RGSC_v3.4 15 60,157,112 - 60,157,466 UniSTS RGSC3.4 RGSC_v3.4 18 29,467,729 - 29,467,936 UniSTS RGSC3.4 Celera 18 28,102,282 - 28,102,489 UniSTS Celera 15 54,005,285 - 54,005,639 UniSTS RH 3.4 Map 18 417.7 UniSTS Cytogenetic Map 18 p11 UniSTS Cytogenetic Map 15 q11-q12 UniSTS Cytogenetic Map 15 q11 UniSTS
AU048166
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 54,324,429 - 54,324,627 (+) MAPPER mRatBN7.2 Rnor_6.0 15 61,207,680 - 61,207,877 NCBI Rnor6.0 Rnor_6.0 15 61,141,190 - 61,141,387 NCBI Rnor6.0 Rnor_5.0 15 64,806,460 - 64,806,657 UniSTS Rnor5.0 Rnor_5.0 15 64,872,950 - 64,873,147 UniSTS Rnor5.0 RGSC_v3.4 15 60,065,439 - 60,065,636 UniSTS RGSC3.4 Celera 15 53,914,382 - 53,914,579 UniSTS Cytogenetic Map 15 q11-q12 UniSTS
BF390452
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 54,254,161 - 54,254,316 (+) MAPPER mRatBN7.2 Rnor_6.0 15 61,070,877 - 61,071,031 NCBI Rnor6.0 Rnor_5.0 15 64,736,147 - 64,736,301 UniSTS Rnor5.0 RGSC_v3.4 15 59,995,178 - 59,995,332 UniSTS RGSC3.4 Celera 15 53,844,124 - 53,844,278 UniSTS RH 3.4 Map 15 458.7 UniSTS Cytogenetic Map 15 q11-q12 UniSTS
AW535983
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 15 54,314,352 - 54,314,502 (+) MAPPER mRatBN7.2 Rnor_6.0 15 61,197,603 - 61,197,752 NCBI Rnor6.0 Rnor_6.0 15 61,131,113 - 61,131,262 NCBI Rnor6.0 Rnor_5.0 15 64,862,873 - 64,863,022 UniSTS Rnor5.0 Rnor_5.0 15 64,796,383 - 64,796,532 UniSTS Rnor5.0 RGSC_v3.4 15 60,055,362 - 60,055,511 UniSTS RGSC3.4 Celera 15 53,904,305 - 53,904,454 UniSTS RH 3.4 Map 15 456.4 UniSTS Cytogenetic Map 15 q11-q12 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000084333 ⟹ ENSRNOP00000072799
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 15 54,252,584 - 54,576,870 (+) Ensembl Rnor_6.0 Ensembl 15 61,069,581 - 61,152,506 (+) Ensembl
RefSeq Acc Id:
NM_001427283 ⟹ NP_001414212
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 60,661,877 - 60,985,971 (+) NCBI
RefSeq Acc Id:
XM_039094044 ⟹ XP_038949972
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 60,681,484 - 60,985,954 (+) NCBI mRatBN7.2 15 54,253,008 - 54,576,871 (+) NCBI
RefSeq Acc Id:
XM_039094045 ⟹ XP_038949973
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 60,789,178 - 60,985,954 (+) NCBI mRatBN7.2 15 54,380,080 - 54,576,871 (+) NCBI
RefSeq Acc Id:
XM_063274157 ⟹ XP_063130227
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 60,661,764 - 60,985,954 (+) NCBI
RefSeq Acc Id:
XM_063274158 ⟹ XP_063130228
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 15 60,851,713 - 60,985,954 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000072799 ⟸ ENSRNOT00000084333
RefSeq Acc Id:
XP_038949972 ⟸ XM_039094044
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_038949973 ⟸ XM_039094045
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_063130227 ⟸ XM_063274157
- Peptide Label:
isoform X1
RefSeq Acc Id:
NP_001414212 ⟸ NM_001427283
- UniProtKB:
A0A0G2K3W1 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063130228 ⟸ XM_063274158
- Peptide Label:
isoform X4
RGD ID: 13699846 Promoter ID: EPDNEW_R10367 Type: initiation region Name: Vwa8_1 Description: von Willebrand factor A domain containing 8 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 15 61,069,486 - 61,069,546 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2012-10-10
Vwa8
von Willebrand factor A domain containing 8
RGD1308772
similar to KIAA0564 protein
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2008-04-30
RGD1308772
similar to KIAA0564 protein
RGD1308772_predicted
similar to KIAA0564 protein (predicted)
'predicted' is removed
2292626 APPROVED
2005-01-20
RGD1308772_predicted
similar to KIAA0564 protein (predicted)
LOC290381_predicted
Symbol and Name status set to approved
1331353 APPROVED
2005-01-12
LOC290381_predicted
similar to KIAA0564 protein (predicted)
Symbol and Name status set to provisional
70820 PROVISIONAL
